Journal article icon

Journal article

Immunogenicity of a bivalent adjuvanted glycoconjugate vaccine against salmonella typhimurium and salmonella enteritidis.

Abstract:

Salmonella enterica serovars Typhimurium and Enteritidis are the predominant causes of invasive non-typhoidal Salmonella (iNTS) disease. Considering the co-endemicity of S. Typhimurium and S. Enteritidis, a bivalent vaccine formulation against both pathogens is necessary for protection against iNTS disease, thus investigation of glycoconjugate combination is required. In the present work, we investigated the immune responses induced by S. Typhimurium and S. Enteritidis monovalent and bivalent...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.3389/fimmu.2017.00168

Authors


Fiorino, F More by this author
Rondini, S More by this author
Lanzilao, L More by this author
Expand authors...
Novartis Vaccine for Global Health More from this funder
Publisher:
Frontiers Media Publisher's website
Journal:
Frontiers in Immunology Journal website
Volume:
8
Issue:
FEB
Pages:
168
Publication date:
2017-02-05
Acceptance date:
2017-02-02
DOI:
ISSN:
1664-3224
Pubs id:
pubs:686612
URN:
uri:5686014a-d9e0-4a76-b221-f0772bb31e9d
UUID:
uuid:5686014a-d9e0-4a76-b221-f0772bb31e9d
Local pid:
pubs:686612

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP